CRISPR & The CIA: 2023 Next Industrial Revolution Outlook (XDNA ETF) – Kelly ETFs – 12.12.22

Overview:
Title: CRISPR & The CIA: 2023 Next Industrial Revolution Outlook (XDNA ETF)
Date: Monday, December 12, 2022
Time: 1:00 PM Eastern Standard Time
Duration: 1 hour

Register Now:
Already Registered?
*I am a financial professional. I understand that this event is for financial professionals only, and I may be contacted by the sponsor.

Summary:

Now On Demand

A pivotal event just happened in the fourth industrial revolution as The CIA Just Invested in Woolly Mammoth Resurrection Technology (a CRISPR start-up) and the White House issued an Executive Order, “to develop genetic engineering technologies and techniques.”

What distinguishes this industrial revolution, from the previous, is that it will be predicated by the changes in life sciences and healthcare due to CRISPR and genomic editing. The Kelly CRISPR & Gene Editing Technology ETF (Nasdaq: XDNA) is designed to capitalize on the next generation of healthcare by investing in over twenty-five CRISPR & Gene Editing companies.

Throughout history, society has been transformed through the industrial revolutions. The previous industrial revolutions focused on the impact that technology has on our resources: agriculture, energy, metallurgy, textiles, chemicals, and transportation. Participants will learn how the Kelly CRISPR & Gene Editing Technology ETF (Nasdaq: XDNA) is designed to capitalize on the next generation of healthcare by investing in CRISPR & Gene Editing companies disrupting the genomic and life science industries.

Participants will learn:

  • What is CRISPR & Gene Editing Technology
  • 2023 Catalysts
  • The Future of Gene Editing and Data due in 2023
  • The Publicly Traded Companies
  • The CRISPR & Gene Editing Sub-Sectors: CRISPR & Gene Editing Technology, Gene Editing Development Solutions, Gene Editing Sequencing Solutions
  • How to Implement the Kelly CRISPR & Gene Editing Technology ETF (Nasdaq: XDNA)

Speaker:
Kevin Kelly Kevin Kelly Founder, Chief Executive Officer Kelly Intelligence │ Kelly ETFs

At Kelly ETFs, Kevin is responsible for ETF product design, structuring, managing retail and institutional investment research, and capital markets. Kevin is the Founder and CEO of Kelly Intelligence, an investment management and intelligence firm that seeks to bring cutting-edge products, with forward-looking exposure. Its growing suite of indexes provide highly liquid, pure-play access to innovative business models, emerging industries, and disruptive technologies. He is the creator and sponsor of the SRVR and INDS ETFs. In September 2014, Nasdaq named Kevin an ‘ETF Insider,’ and he is a recognized leader in ETF design, distribution and growth with his extensive track record of launching multi-billion dollar ETFs. Kevin’s thought leadership on markets, derivatives, e-commerce, and technology can be found weekly in top media outlets.
Limited Operating History Risk. The Fund is a recently organized investment company with a limited operating history. As a result, prospective investors have a limited track record or history on which to base their investment decision.

DNA Modification Technology Company Risk. DNA modification technology companies face intense competition, and products and services with a potentially short product life. These companies will generally require large amounts of capital expenditures on research and development, with no guarantee that the product or service would be successful. They may be heavily dependent on intellectual property rights. The laws related to these rights can vary and there is no guarantee that a company will be able to successfully protect their intellectual property rights. These companies, like other health care companies, are subject to various government and regulator oversight that could hamper or impede their operations.

Foreign Securities Risk. Investments in non-U.S. securities involve certain risks that may not be present with investments in U.S. securities. For example, investments in non-U.S. securities may be subject to risk of loss due to foreign currency fluctuations or to political or economic instability.

Investing involves risk including possible loss of principal.

Before investing carefully consider a funds investment objective, risks, charges, and expenses contained in the prospectus available at KELLY ETFs. Read carefully before investing.

Distributor: Foreside Fund Services, LLC.